WALTHAM, Mass., Sep 09, 2010 (BUSINESS WIRE) --
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving
science, announced that its board of directors has authorized the
repurchase of an additional $750 million of shares of its own common
stock in the open market or in negotiated transactions. The new
repurchase authorization will remain in effect through September 8, 2011.
This follows an earlier repurchase authorization of $750 million of
shares, of which $188 million remains, that is still in effect until
April 20, 2011.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving
science. Our mission is to enable our customers to make the world
healthier, cleaner and safer. With revenues of more than $10 billion, we
have approximately 35,000 employees and serve customers within
pharmaceutical and biotech companies, hospitals and clinical diagnostic
labs, universities, research institutions and government agencies, as
well as in environmental and process control industries. We create value
for our key stakeholders through two premier brands, Thermo Scientific
and Fisher Scientific, which offer a unique combination of continuous
technology development and the most convenient purchasing options. Our
products and services help accelerate the pace of scientific discovery,
and solve analytical challenges ranging from complex research to routine
testing to field applications. Visit www.thermofisher.com.
SOURCE: Thermo Fisher Scientific Inc.
Media Contact Information:
Ron O'Brien, 781-622-1242
Investor Contact Information:
Ken Apicerno, 781-622-1294